These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1638 related articles for article (PubMed ID: 25810047)

  • 1. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
    Wells SA; Asa SL; Dralle H; Elisei R; Evans DB; Gagel RF; Lee N; Machens A; Moley JF; Pacini F; Raue F; Frank-Raue K; Robinson B; Rosenthal MS; Santoro M; Schlumberger M; Shah M; Waguespack SG;
    Thyroid; 2015 Jun; 25(6):567-610. PubMed ID: 25810047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and Clinical Presentation of Medullary Thyroid Carcinoma.
    Raue F; Frank-Raue K
    Recent Results Cancer Res; 2015; 204():61-90. PubMed ID: 26494384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma.
    Elisei R; Bottici V; Cappagli V; Ramone T; Tacito A; Ciampi R; Romei C
    Ann Endocrinol (Paris); 2019 Jun; 80(3):187-190. PubMed ID: 31053251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critically evaluated key points on hereditary medullary thyroid carcinoma.
    Zhang D; Liang N; Sun H; Frattini F; Sui C; Yang M; Wang H; Dionigi G
    Front Endocrinol (Lausanne); 2024; 15():1412942. PubMed ID: 38919477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RET Y791F Variant Does Not Increase the Risk for Medullary Thyroid Carcinoma.
    Toledo RA; Maciel RM; Erlic Z; Lourenço DM; Cerutti JM; Eng C; Neumann HP; Toledo SP
    Thyroid; 2015 Aug; 25(8):973-4. PubMed ID: 25950813
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update.
    Wells SA; Pacini F; Robinson BG; Santoro M
    J Clin Endocrinol Metab; 2013 Aug; 98(8):3149-64. PubMed ID: 23744408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Management of multiple endocrine neoplasia syndrome type 2 families in association with rare germline mutations of the RET proto-oncogene].
    Fitze G; Saeger HD; Roesner D; Schackert HK
    Klin Padiatr; 2004; 216(5):270-6. PubMed ID: 15455293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple endocrine neoplasia type 2: recent progress in diagnosis and management.
    Heshmati HM; Hofbauer LC
    Eur J Endocrinol; 1997 Dec; 137(6):572-8. PubMed ID: 9437218
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiple endocrine neoplasia type 2.
    Lodish M
    Front Horm Res; 2013; 41():16-29. PubMed ID: 23652668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer?
    Romei C; Tacito A; Molinaro E; Agate L; Bottici V; Viola D; Matrone A; Biagini A; Casella F; Ciampi R; Materazzi G; Miccoli P; Torregrossa L; Ugolini C; Basolo F; Vitti P; Elisei R
    Clin Endocrinol (Oxf); 2015 Jun; 82(6):892-9. PubMed ID: 25440022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RET oncogene in MEN2, MEN2B, MTC and other forms of thyroid cancer.
    Lodish MB; Stratakis CA
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):625-32. PubMed ID: 18402529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and surgical dilemmas in hereditary medullary thyroid carcinoma.
    Allen SM; Bodenner D; Suen JY; Richter GT
    Laryngoscope; 2009 Jul; 119(7):1303-11. PubMed ID: 19444888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sporadic and familial medullary thyroid carcinoma: state of the art.
    Moo-Young TA; Traugott AL; Moley JF
    Surg Clin North Am; 2009 Oct; 89(5):1193-204. PubMed ID: 19836492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of medullary thyroid carcinoma: current approaches in diagnosis and treatment.
    Boikos SA; Stratakis CA
    Histol Histopathol; 2008 Jan; 23(1):109-16. PubMed ID: 17952863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current understanding and management of medullary thyroid cancer.
    Roy M; Chen H; Sippel RS
    Oncologist; 2013; 18(10):1093-100. PubMed ID: 24037980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multiple endocrine neoplasia type 2a and 2b].
    Vestergaard P
    Ugeskr Laeger; 1996 Jan; 158(5):590-3. PubMed ID: 8607216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary medullary thyroid carcinoma syndromes: experience from western India.
    Diwaker C; Sarathi V; Jaiswal SK; Shah R; Deshmukh A; Thomas AE; Prakash G; Malhotra G; Patil V; Lila A; Shah N; Bandgar T
    Fam Cancer; 2021 Jul; 20(3):241-251. PubMed ID: 33392850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline RET mutation carriers in Japanese patients with apparently sporadic medullary thyroid carcinoma: A single institution experience.
    Kihara M; Miyauchi A; Yoshioka K; Oda H; Nakayama A; Sasai H; Yabuta T; Masuoka H; Higashiyama T; Fukushima M; Ito Y; Kobayashi K; Miya A
    Auris Nasus Larynx; 2016 Oct; 43(5):551-5. PubMed ID: 26837867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multiple endocrine neoplasia type 2].
    Maia AL; Gross JL; Puñales MK
    Arq Bras Endocrinol Metabol; 2005 Oct; 49(5):725-34. PubMed ID: 16444355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple endocrine neoplasia type II and familial medullary thyroid carcinoma. Impact of genetic screening on management.
    Gagel RF
    Cancer Treat Res; 1997; 89():421-41. PubMed ID: 9204204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 82.